Adeel Ahmad

Adeel Ahmad

Auto-generated profile, based on publicly available information

Adeel Ahmad

Texas Tech Health Sciences Center El Paso 2000B Woodrow Bean Transmountain Rd., B323 79911 El Paso TX USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
LALuis Alvarado
Luis Alvarado
NSNishtha Sharma
Nishtha Sharma
RLRoxann Lerma
Roxann Lerma
ADAlok Kumar Dwivedi
Alok Kumar Dwivedi
AAAdeel Ahmad
Adeel Ahmad
EAEyas Alkhalili
Eyas Alkhalili
Background: Secondary hyperparathyroidism in patients with end stage renal disease on dialysis is associated with bone pain and fractures in addition to cardiovascular morbidity. Cinacalcet is the most commonly used drug to treat such patients, but it has never been compared to surgery. The goal of this study is to compare the long‐term outcomes and survival between cinacalcet and parathyroidectomy in the treatment of secondary hyperparathyroidism in hemodialysis patients.Methods: Adult patients on hemodialysis who were treated with cinacalcet or parathyroidectomy in the United States Renal Data System were included. Patients treated with surgery (n = 2023) were compared using 1:1 propensity score matching ratio to a cohort of patients treated with cinacalcet. A Cox regression analysis was conducted to compare the overall mortality.Results: The propensity score matching successfully created two groups with similar demographics. Patients in the surgery group had a higher mean peak PTH level prior to therapy (2066.8 vs 1425.4, P < 0.001). No difference was observed in the development of new‐onset coronary artery disease (7.7% vs 7.9%, P = 0.8) or cerebrovascular disease (7% vs 6.7%, P = 0.8). Surgical patients had a higher rate of pathologic fractures (27.8% vs 24.9%, P = 0.04). Survival analysis showed that patients undergoing surgery had a better 5‐year survival (65.6% vs 57.8%) and were less likely to die within the study period (HR 0.77, 95% CI 0.7–0.85, P < 0.0001).Conclusions: Patients on dialysis undergoing parathyroidectomy for the treatment of secondary hyperparathyroidism have a better overall survival than those treated with cinacalcet.

27 March 2013 in Case Reports in Nephrology
Verified
Journal Article
Open access
PDF file
HSHasan J. Salameh
Hasan J. Salameh
AAAdeel Ahmad
Adeel Ahmad
TKTina Kochar
Tina Kochar
Multiple myeloma (MM) is an uncommon hematologic malignancy accounting for 1% of all malignancies. Renal involvement is a common complication of MM. Rapid intervention to reverse renal dysfunction may be critical for management, especially in patients with light chain cast nephropathy. Recovery rate ranges from 5% to 15%. We describe an atypical presentation of MM in a young patient who presented with severe renal insufficiency requiring renal replacement therapy and achieved complete renal recovery with chemotherapy.